73 min listen
Dr. Josh Bloom Part 1- Gabapentin and fallout of the CDC Guidelines - Episode 22
Dr. Josh Bloom Part 1- Gabapentin and fallout of the CDC Guidelines - Episode 22
ratings:
Length:
45 minutes
Released:
May 3, 2023
Format:
Podcast episode
Description
Listen to part 1 of DPF's interview with Dr. Josh Bloom. Why are so many pain patients put on Gabapentin? Does it work? Why are so many being prescribed Gabapentin all of a sudden? What are some of the possible side effects? Listen to some patient stories about Gabapentin. Stay tuned for Part 2 with Josh Bloom.
Josh Bloom's bio:
"Director of Chemical and Pharmaceutical Sciences
Dr. Josh Bloom earned a Ph.D. in organic chemistry from the University of Virginia, followed by postdoctoral training at the University of Pennsylvania.He worked for more than two decades as a research chemist for Lederle Laboratories, which was acquired by Wyeth in 1994, which itself was acquired by Pfizer in 2009.
During this time he worked in a number of therapeutic areas, including diabetes and obesity, antimicrobial agents, HIV/AIDS, hepatitis C, and oncology. His group discovered the novel antibiotic Tygacil®, which was approved by the FDA for use against resistant bacterial infections in 2005.
He is the author of 25 patents, and 35 academic papers, including a chapter on new therapies for hepatitis C in Burger s Medicinal Chemistry, Drug Discovery and Development, 7th Edition (Wiley, 2010), and has given numerous public lectures on how the pharmaceutical industry really works.
Dr. Bloom joined the American Council on Science and Health in 2010 as ACSH s Director of Chemical and Pharmaceutical Sciences, and has written more than 20 op-eds, which have appeared in major publications, including The Wall Street Journal, Forbes, The New York Post, National Review Online and Medical Progress Today. Dr. Bloom is a regular contributor to Science 2.0, where he writes on topics related to the pharmaceutical industry, medicine and junk science.
In this episode, we included quotes from two ACSH podcasts. They are:
Podcast: Neurontin — The Lousy Opioid Alternative; Twitter Censors ACSH
Podcast: Tylenol After Surgery is Useless
Dr. Josh Bloom's articles about Gabapentin:
The Devil You Know - Neurontin's Massive Flop As An Opioid Alternative
Neurontin: The Darling Of The Anti-Opioid Crowd. But Does It Work?
Neurontin: Over-Hyped And Underwhelming
Source of graph showing opioid prescribing is down to 1992 level
Other patient comments about Gabapentin experiences. Please join this FB group in order to view this post, since it is a closed group.
DPF's Patreon page announcement!
Disclaimer: The information that has been provided to you in this podcast is not to be considered legal or medical advice.
---
Send in a voice message: https://podcasters.spotify.com/pod/show/the-doctor-patient-forum/message
Support this podcast: https://podcasters.spotify.com/pod/show/the-doctor-patient-forum/support
Josh Bloom's bio:
"Director of Chemical and Pharmaceutical Sciences
Dr. Josh Bloom earned a Ph.D. in organic chemistry from the University of Virginia, followed by postdoctoral training at the University of Pennsylvania.He worked for more than two decades as a research chemist for Lederle Laboratories, which was acquired by Wyeth in 1994, which itself was acquired by Pfizer in 2009.
During this time he worked in a number of therapeutic areas, including diabetes and obesity, antimicrobial agents, HIV/AIDS, hepatitis C, and oncology. His group discovered the novel antibiotic Tygacil®, which was approved by the FDA for use against resistant bacterial infections in 2005.
He is the author of 25 patents, and 35 academic papers, including a chapter on new therapies for hepatitis C in Burger s Medicinal Chemistry, Drug Discovery and Development, 7th Edition (Wiley, 2010), and has given numerous public lectures on how the pharmaceutical industry really works.
Dr. Bloom joined the American Council on Science and Health in 2010 as ACSH s Director of Chemical and Pharmaceutical Sciences, and has written more than 20 op-eds, which have appeared in major publications, including The Wall Street Journal, Forbes, The New York Post, National Review Online and Medical Progress Today. Dr. Bloom is a regular contributor to Science 2.0, where he writes on topics related to the pharmaceutical industry, medicine and junk science.
In this episode, we included quotes from two ACSH podcasts. They are:
Podcast: Neurontin — The Lousy Opioid Alternative; Twitter Censors ACSH
Podcast: Tylenol After Surgery is Useless
Dr. Josh Bloom's articles about Gabapentin:
The Devil You Know - Neurontin's Massive Flop As An Opioid Alternative
Neurontin: The Darling Of The Anti-Opioid Crowd. But Does It Work?
Neurontin: Over-Hyped And Underwhelming
Source of graph showing opioid prescribing is down to 1992 level
Other patient comments about Gabapentin experiences. Please join this FB group in order to view this post, since it is a closed group.
DPF's Patreon page announcement!
Disclaimer: The information that has been provided to you in this podcast is not to be considered legal or medical advice.
---
Send in a voice message: https://podcasters.spotify.com/pod/show/the-doctor-patient-forum/message
Support this podcast: https://podcasters.spotify.com/pod/show/the-doctor-patient-forum/support
Released:
May 3, 2023
Format:
Podcast episode
Titles in the series (48)
Part 4 - PDMP/NarxCare - Jacob James Rich - PDMP and Law Enforcement by The Doctor Patient Forum